Hemostasis and Thrombosis/Coagulation Flashcards

1
Q

Describe the differences among primary, secondary and tertiary hemostasis

A

primary - platelet aggregation and forming a “plug”

secondary - stabilizing the plug and adding fibrin/coag cascade

tertiary - breaking the plug down during repair (via plasmin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Under normal circumstances, endothelial cells secrete ___ which inhibits platelet function, and ___ which is a vasodilator to maintain blood flow and prevent clotting. ___ is also produced and converts plasminogen to plasmin which __

A

Under normal circumstances, endothelial cells secrete prostaglandin I2 (prostacyclin) which inhibits platelet function, and nitric oxide which is a vasodilator to maintain blood flow and prevent clotting. Tissue plasminogen activator (TPA) is also produced and converts plasminogen to plasmin which breaks down clots

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

TFPI works by directly inhibiting factor __ and through TF, inhibits factor __ in the coag cascade

A

TFPI works by directly inhibiting factor 10a and through TF, inhibits factor 7 in the coag cascade

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

On the surface of the endothelial cells are ___, which inhibits thrombin and factor 10a, and ___, which does what?

A

On the surface of the endothelial cells are heparan sulfate, which inhibits thrombin and factor 10a, and thrombomodulin, which binds to thrombin, ultimately leading to the breakdown of factors 5a and 8a

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe how thrombomodulin works. What are the roles of Protein C and S?

A

(see image below)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Inside the dense granules of platelets are calcium, ___, and ___.

alpha granules contain von-Willibrand’s factor, ___, ___, fibrinogen and fibronectin, ___ and PF4

A

Inside the dense granules of platelets are calcium, ATP/ADP, and serotonin.

alpha granules contain von-Willibrand’s factor, platelet derived growth factor (PDGF), P selectin, fibrinogen and fibronectin, TGF-B, PF4, Protein S, PAT 1 and procoagulant factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the functions of the following factors released by platelets?

(vWF, fibrinogen, fibronectin, thrombospondin, P-selectin, GPIIb/IIIa)

(Factor V, XI and XIII)

(Protein S)

(Plasminogen activator inhibitor-1)

(Platelet Factor-4)

(Platelet derived growth factor)

(TGF β)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

The first step in forming a blood clot is ___, mediated by ___ which is released by endothelial cells

A

The first step in forming a blood clot is reflex vasoconstriction, mediated by endothelin which is released by endothelial cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

The 2nd step in forming a blood clot is ___, which is mediated by ___ and ___ that are in the subendothelial matrix. Both of these help to tether the platelet to the damaged vessel

A

The 2nd step in forming a blood clot is platelet adhesion, which is mediated by vWF (bound by GPIb/9) and collagen (GP6) that are in the subendothelial matrix. Both of these help to tether the platelet to the damaged vessel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Platelet activation and degranulation are mediated by ___ whose conformational change exposes the binding sites for vWF and fibrinogen. ___ and ___(platelet agonist) are also released

A

Platelet activation and degranulation are mediated by GPIIb/IIIa whose conformational change exposes the binding sites for vWF and fibrinogen. ADP and thromboxane (platelet agonist) are also released

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Step 4 in forming a blood clot is ___, which involves platelet binding to fibrinogen and can be inhibited by aspirin

A

Step 4 in forming a blood clot is platelet aggregation, which involves platelet binding to fibrinogen and can be inhibited by aspirin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe a platelet aggregation study

What are 3 other ways you could measure platelet activity in a pts sample (measuring platelet quantity)?

A
  • CBC: # of platelets
  • Peripheral smear
  • Bone marrow biopsy

Platelet aggregation study: Platelets in plasma >> measure baseline light transmission >> + platelet agonist >> wait for clot to form then measure second light transmission >> difference between initial and final transmission = amt of platelet clumping = degree of platelet function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the platelet function assay. How do you interpret the results of the study?

A

Put sample of blood thru small opening surrounded by biologically active membrane; membrane is coated w/ collagen + adp/epinephrine (factors that help w/ clot formation) and a clot forms

You do the collagen/epi test first.

Normal closing time for collagen/epinephrine test= no defect; If closing time is prolonged, then you do the collagen/ADP test

If closing time for col/adp test normal, problem is aspirin induced platelet dysfunction (probably tell this from patient’s history); If closing time = prolonged, DDx = thrombocytopenia (check platelet count) or some other defect not due to aspirin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Match the coagulation factors to their names:

I

Fibrinogen

Prothrombin

III

Thromboplastin

II

IV

Calcium

A

I Fibrinogen

II Prothrombin

III Thromboplastin

IV Calcium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Number the following coagulation factors:

Proaccelerin

Same as V

Proconvertin

Antihemophilic

A

Proaccelerin: V

Same as V: VI

Proconvertin: VII

Antihemophilic: VIII

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Name the following coagulation factors:

IX

X

XI

XII

XIII

A

IX Christmas

X Stuart-Prower

XI Plasma thrombo-plastin antecedent

XII Hageman

XIII Fibrin stabilizing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Outline the intrinsic pathway of the coag cascade

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Outline the extrinsic pathway of the coag cascade

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Describe the role of Calcium (aka Factor IV) in the coag cascade. What is the function of thrombin in the coag casade?

A

Calcium has a net + charge; PL scramblase creates negatively charged phosphotidyl serine rafts that bind to one of calcium’s +ve charges, and the coagulation factors (also –vely charged, can bind to the other +ve charge)

(basically calcium helps to bind the coagulation factors to the platelet membrane)

Thrombin acts as an activator >> promotes positive feedback

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Factors 2, __, __ and 10 are Vitamin K dependent

While the rest of the coag factors are made in the liver, only factor __ is made by endothelial cells

A

Factors 2, 7, 9 and 10 are Vitamin K dependent (remember 7+2=9 and 10 is Kind)

While the rest of the coag factors are made in the liver, only factor 8 is made by endothelial cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

The prothrombin (PT) time test measures the activation of which pathway of thecoag cascade? Which factors are being measured in the test?

Briefly describe the test

A

Extrinsic (remember PT = 2 letters, extrinsic has 2 i’s in it)

Fcators 7, X, V, II and fibrinogen

(see below)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Which pathway of the coag cascade does the PTT test?

The test will be prolonged with ___ and any other factor deficiency except __ and __

A

Intrinsic and common

Heparin; VII and XIII

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Thrombin time measures the conversion of ___ to ___ upon addition of ___ to a patient’s plasma sample

A prolonged thrombin time would suggest a deficiency in ___

A

Thrombin time measures the conversion of fibrinogen to fibrin upon addition of thrombin to a patient’s plasma sample

A prolonged thrombin time would suggest a deficiency in fibrinogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Patients lacking __, __, or __ have a long aPTT but no bleeding

Patients lacking FXI have a ___ aPTT and __

Patients lacking ___ or ___ have an equally long aPTT and ___ bleeding

A
  • Patients lacking FXII, HMK, or PK have a long aPTT but no bleeding
  • Patients lacking FXI have a long aPTT and may or may not have bleeding
  • Patients lacking FVIII or FIX have an equally long aPTT and serious bleeding
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Describe the mixed study to determine the presence of a factor deficiency or the presence of a factor inhibitor. How would you interpret the results of the test?

A

(see image below)

Mix patient plasma (sans deficiency) w/ normal plasma >> if clotting time is prolonged, there’s a factor inhibitor (right, b/c you should see normal clotting time a longer time suggests that they’re inhibitors in the pt sample that are blocking the clotting process)

Mix patient plasma (+ clotting factor deficiency) w/ normal plasma >>if clotting time is normal or goes down to near normal, this suggests a clotting factor deficiency (which makes sense because if there is a deficiency, the only reason we’re able to form a clot is because of the normal plasma which has normal levels of clotting factors in it)

26
Q

Is there any way to measure how all the parts of the coagulation system work together? Explain how this works.

A

Sure, the #TEG

Basically the pin is spun until the clot forms and restricts spinning of pin. The pressure against the pin = tracing

27
Q

Match the following conditions and tracings

A
28
Q

The disorders of platelet dysfunction include ___ and ___

A

Platelet defects and von Willibrands disease

29
Q

Describe the clinical presentation of platelet defects

A

Petechiae (small, unraised patches on skin or mucus membranes)

Mucosal bleeding

Bruising

30
Q

___, also known as low platelet count is a qauantitative platelet defect that can arise from decrased marrow production of platelets, increased consumption or splenic sequestration

A

Thrombocytopenia, also known as low platelet count is a quantitative platelet defect that can arise from decrased marrow production of platelets, increased consumption or splenic sequestration

31
Q

___ and ___ are examples of inherited qualitative platelet disorders

Which of these is characterized by a deficiency in GP1b, resulting in impaired platelet adhesion?

Which of these is characterized by GPIIb/IIIa deficiency, leading to impaired platelet aggregation?

A

Bernard-Soulier syndrome and Glanzmann thrombasthenia are examples of inherited qualitative platelet disorders

Bernard-Soulier syndrome is characterized by a deficiency in GP1b, resulting in impaired platelet adhesion?

Glanzmann thrombasthenia is characterized by GPIIb/IIIa deficiency, leading to impaired platelet aggregation?

32
Q

In Bernard-Soulier syndrome, ___ is dificient, which impairs platelet adhesion due to inability to bind vWF

In Glanzmann thrombasthenia, we can’t bind ___ due to adeficienciy in GPIIb/IIIa, thus impairing platelet ___

A

In Bernard-Soulier syndrome, GP1b is dificient, which impairs platelet adhesion due to inability to bind vWF

In Glanzmann thrombasthenia, we can’t bind fibrinogen due to a deficienciy in GPIIb/IIIa, thus impairing platelet aggregation

33
Q

Type I and 3 von Willebrand’s disease are characterized by a (defect/deficiency) in ___ vWF, resulting in impaired platelet adhesion

Type 2 von Willebrand’s disease is characterized by a (defect/deficiency) in ___ vWF, resulting in impaired platelet adhesion

A

Type I and 3 von Willebrand’s disease are characterized by a deficiency in vWF, resulting in impaired platelet adhesion

Type 2 von Willebrand’s disease is characterized by a defect in vWF, resulting in impaired platelet adhesion

34
Q

What kind of graphs would you expect to see in a platelet aggregation study to distinguish between Bernard-soulier syndrome and Glanzmann thrombastenia?

A
35
Q

How does aspirin work to prevent platelet aggregation?

A

Aspirin inhibits COX which mediates the production of prostaglandins (PGH2) that later become thomboxane, which is necessary for platelet aggregation

36
Q

Besides its role in platelet aggregation, von Willebrand’s factor also does what with factor 8? What is the inheritance pattern of vW disease?

T/F: vW disease is the most common inherited bleeding disorder

A

Binds factor VIII and extends its halflife/prevents its inactivation

Autosomal dominant

Truth

37
Q

How would you treat von Willebrand’s disease?

What kind of results would you expect with PTT,PT and ristocetin tests?

A

Give desmopressin (DDavp) which increases vWF release from Weibel-Palade bodies

PTT: increased; PT: normal; Ristocetin: abnormal

38
Q

Types 2A and 2M vW disease both involve a ___ vWF-dependent platelet adhesion, with type __ having deficient HMW multimers and type ___ having normal levels of multimers

A

Types 2A and 2M vW disease both involve a decreased vWF-dependent platelet adhesion, with type 2A having deficient HMW multimers and type 2M having normal levels of multimers

39
Q

Type ___ vW disease is a partial vWF deficiency, whereas type ___ vW disease is a complete deficiency

A

Type 1 vW disease is a partial vWF deficiency, whereas type 3 vW disease is a complete deficiency

40
Q

Type 2B vW disease involves increased affinity for which protein?

Type 2N involves patients presenting hemophilia symtpoms because?

A

Type 2B vW disease involves increased affinity for GPIb alpha

Type 2N involves patients presenting hemophilia symtpoms because patients can’t prevent deactivation of factor 8 since they have decreased vWF binding affinity for factor 8 (inheritance pattern doesn’t fit hemophilia though)

41
Q

What are the ways in which you could test for vW disease?

A

Check vW antigen level

Measure factor 8 activity

Measure vWF activity using ristocetin

Multimer assay

42
Q

PT is used to monitor ___, whereas PTT is used to monitor ___

A

PT is used to monitor warfarin, PTT is used to monitor heparin

43
Q

Disease of secondary hemostasis include ___, anti-coagulation, and ___

A

Disease of secondary hemostasis include Vitamin K deficiency, anti-coagulation, and hemophilia (genetic/acquired)

44
Q

Common causes of prolonged PT include Vit K deficiency, ___, ___ and DIC

A

Common causes of prolonged PT include Vit K deficiency, warfarin, liver disease and DIC

45
Q

How does warfarin work to block clot formation?

A

Clotting factors have glutamate residue, which becomes carboxylated (gives clotting factor negative charge necessary for binding calcium)

Warfarin blocks effects of epoxide reductase (which recycles Vit K back to functional form so we can get carboxyl group to bind calcium)

Inability to bind calcium >> can’t proceed with clotting cascade

46
Q

Common causes of prolonged PTT include factor defects, esp those in factors ___, ___, ___ and ___; heparin use; antiphospholipid antibody and DIC

A

Common causes of prolonged PTT include factor defects, esp those in factors 8, 9, 11 and 12; heparin use; antiphospholipid antibody and DIC

47
Q

Primary targets of heparin are factor ___ and ___, and secondary targets are factor ___ and ___

How does heparin work?

A

Primary targets of heparin are factor 12a and 11a, and secondary targets are factor 10a and thrombin

Heparin inactivates thrombin and activated factor X (Xa) through antithrombin (AT)-dependent mechanism

48
Q

What patterns of PT and PTT results would you see in defects in the extrinsic, intrinsic or common pathway? which factors are affected?

A
49
Q

Explain what happens with disseminated intravascular coagulation

What are the downstream effects of DIC and how do they occur?

A

Systematic activation of clotting system due to existing illness (in this case, clotting is activated by sepsis, which the body responds to by activating inflammatory mechanisms that then shut down anti-coagulation mechanisms so clotting is constantly on)

End organ damage due to clot travelling to smaller and smaller vessels, resulting in occlusion, and bleeding due to platelet depletion (coz we’re clotting so much)

50
Q

Why would you see prolonged thrombin time, PTT and PT in the case of DIC?

A

You’re using up too many of your platelets with these pathologic clots that you’re forming so your fibrinogen drops, which prolongs all of these measures (in other ords, b/c you’re clotting so much, your levels of fibrinogen and platelet ct drop, which prolongs all those test times)

51
Q

Morphologically, what kinds of cellswould you see in a smear of a pt who has DIC?

A

Helmet cells and schistocytes

52
Q

___ is an X linked recessive disorder of Factor 8 caused by a partial inversion of intron 22 on the X chromosome

Hemophilia B (aka Christmas disease) is caused by a deficiency in Factor __ due to a missense mutation.

A

Hemophilia A (Ate rHymes with 8)

Factor 9 (remember factor 9 is Christmas factor; also if you turn 9 around and add a bottom hump, it looks like a B)

53
Q

___ deficiency presents with milder symptoms compared to Hemophilia A and B, and is an AR disorder

Patients w/ ___ deficiency experience delayed bleeding and have NORMAL PT and PTT. (why are these both normal?)

A

factor 11 deficiency

factor 13 deficiency. Both tests measure variables that are outside of factor 13’s function/activation so both values will be normal

54
Q

Factor __ dificiency arises from consanguinity and can be combined w/ factor 7 deficiency, whose symptoms are unrelated to factor 7 levels

Contact factor deficiency is a deficiency is factor __, HMWK or prekallikrein, and is characterized by long PTT w/o clinical bleeding

A

Factor V dificiency arises from consanguinity and can be combined w/ factor 7 deficiency, whose symptoms are unrelated to factor 7 levels

Contact factor deficiency is a deficiency is factor XII, HMWK or prekallikrein

55
Q

One key characteristic of ___ deficiency is umbilical cord hemorrhage

A

Fibrinogen deficiency

56
Q

Treating hemophilia w/ factor 8 concentrates can result in ___, preventing the use of factor 8 when treated with it again

___ is an autoimmune disorder that results from antibodies against phospholipid-binding proteins and is characterized by thromboembolic events and pregnancy morbidities

A

Acquired factor 8 inhibitors (antibodies against factor 8)

Antiphospholipid syndrome

57
Q

Some antibodies seen in APS are anti-___ and ___, which normally bind the phospholipid membrane of platelets and inhibit platelet aggregation

A

Anti-cardiolipin and anti-beta 2 glycoprotein

58
Q

The lupus anticoagulant phenomenon describes what? How would you test for lupus anticoagulant?

A

Prolongation of clotting times in vitro but thrombosis in vivo

Basically do the same corrected mixing test and if it fails, that suggests the presence of an inhibitor. You woulc also add phospholipid to establish phospholipid dependence (so if the time shortens upon addition of phospholipids = phospholipid dependence)

59
Q

Common causes of inherited thrombophilia ass’d with low bleeding risk include ___ (Activated Protein C Resistance) and ___

A

Common causes of inherited thrombophilia ass’d with low bleeding risk include factor V leiden (Activated Protein C Resistance) and Prothrombin 20210

(Factor V Leiden is a proclotting disease - Factor V resistant to Activated Protein C so clotting cascade doesn’t stop)

60
Q

Protein __ and ___ deficiency result in an inability to inactivate factors 5 and 8

A

Protein C and S deficiency result in an inability to inactivate factors 5 and 8

61
Q

___ deficiency results in recurring venous thrombosis (fialure to inhibit factors 2, 9, 10, 11, 12)

____ disorder is caused by a mutation in the thrombin gene (G to A)that results in increased production of thrombin

A

Antithrombin III deficiency results in recurring venous thrombosis (fialure to inhibit factors 2, 9, 10, 11, 12)

Prothrombin G20210A disorder is caused by a mutation in the thrombin gene (G to A)that results in increased production of thrombin